GPSR - Global Pharmaceutical Sciences Review

EVALUATION OF THE KNOWLEDGE OF HEALTH CARE PROFESSIONALS REGARDING THERAPEUTIC DRUG MONITORING IN PUBLIC HOSPITALS OF LAHORE PAKISTAN

http://dx.doi.org/10.31703/gpsr.2020(V-I).02 10.31703/gpsr.2020(V-I).02
Authored by : Anam Arshad , Malik Irfan Zulfiqar , Zahra Hassan Kiani , Maria Hassan Kiani , Muhammad Rauf ul Hassan

02 Pages : 9-16

References

Ali, I., Khan, J., Khan, A., Ullah, I., & Ahmad, F. J. P. O. (2015). Pharmacotherapy evaluation of diabetic patients in ward of general medicine, northwest general hospital & research centre, a case study from Khyber Pakhtunkhwa, Pakistan. 1, 104- 108.
Ates, H. C., Roberts, J. A., Lipman, J., Cass, A. E., Urban, G. A., & Dincer, C. J. T. i. B. (2020). On- site therapeutic drug monitoring.
Ghiculescu, R. (2008). Therapeutic drug monitoring: which drugs, why, when and how to do it.
Gross, Annette S.
Hempel, G. (2004). Drug monitoring and clinical chemistry: Elsevier.
Ismail, M., Iqbal, Z., Hammad, M., Ahsan, S., Sheikh, A. L., Asim, S. M., & Khan, T. M. J. H. (2010). Drug utilization evaluation of piperacillin/tazobactam in a tertiary care teaching hospital. 4, 1044- 1055.
Javangula, H. (2012). An overview of pharmacoeconomics and outcomes research. International Journal of Life Sciences Biotechnology and Pharma Research, 1(1), 58- 63.
Kang, J. S., & Lee, M. H. (2009). Overview of therapeutic drug monitoring. The Korean journal of internal medicine, 24(1), 1.
Wong, G., Sime, F. B., Lipman, J., & Roberts, J. A. J. B. i. d. (2014). How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients? , 14(1), 1-11.

References

Ali, I., Khan, J., Khan, A., Ullah, I., & Ahmad, F. J. P. O. (2015). Pharmacotherapy evaluation of diabetic patients in ward of general medicine, northwest general hospital & research centre, a case study from Khyber Pakhtunkhwa, Pakistan. 1, 104- 108.
Ates, H. C., Roberts, J. A., Lipman, J., Cass, A. E., Urban, G. A., & Dincer, C. J. T. i. B. (2020). On- site therapeutic drug monitoring.
Ghiculescu, R. (2008). Therapeutic drug monitoring: which drugs, why, when and how to do it.
Gross, Annette S.
Hempel, G. (2004). Drug monitoring and clinical chemistry: Elsevier.
Ismail, M., Iqbal, Z., Hammad, M., Ahsan, S., Sheikh, A. L., Asim, S. M., & Khan, T. M. J. H. (2010). Drug utilization evaluation of piperacillin/tazobactam in a tertiary care teaching hospital. 4, 1044- 1055.
Javangula, H. (2012). An overview of pharmacoeconomics and outcomes research. International Journal of Life Sciences Biotechnology and Pharma Research, 1(1), 58- 63.
Kang, J. S., & Lee, M. H. (2009). Overview of therapeutic drug monitoring. The Korean journal of internal medicine, 24(1), 1.
Wong, G., Sime, F. B., Lipman, J., & Roberts, J. A. J. B. i. d. (2014). How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients? , 14(1), 1-11.